Negative Feedback Regulation of IFN-; Pathway by IFN Regulatory Factor 2 in Esophageal Cancers

IFN-; is an antitumor cytokine that inhibits cell proliferation and induces apoptosis after engagement with the IFN-; receptors (IFNGR) expressed on target cells, whereas IFN regulatory factor 2 (IRF-2) is able to block the effects of IFN-; by repressing transcription of IFN-;–induced genes. Thus far, few studies have explored the influences of IFN-; on human esophageal cancer cells. In the present study, therefore, we investigated in detail the functions of IFN-; in esophageal cancer cells. The results in clinical samples of human esophageal cancers showed that the level of IFN-; was increased in tumor tissues and positively correlated with tumor progression and IRF-2 expression, whereas the level of IFNGR1 was decreased and negatively correlated with tumor progression and IRF-2 expression. Consistently, in vitro experiments showed that low concentration of IFN-; induced the expression of IRF-2 with potential promotion of cell growth, and moreover, IRF-2 was able to suppress IFNGR1 transcription in human esophageal cancer cells by binding a specific motif in IFNGR1 promoter, which lowered the sensitivity of esophageal cancer cells to IFN-;. Taken together, our results disclosed a new IRF-2–mediated inhibitory mechanism for IFN-;–induced pathway in esophageal cancer cells: IFN-; induced IRF-2 upregulation, then up-regulated IRF-2 decreased endogenous IFNGR1 level, and finally, the loss of IFNGR1 turned to enhance the resistance of esophageal cancer cells to IFN-;. Accordingly, the results implied that IRF-2 might act as a mediator for the functions of IFN-; and IFNGR1 in human esophageal cancers. [Cancer Res 2008;68(4):1136–43]